Unlock instant, AI-driven research and patent intelligence for your innovation.

Stem cell maturation method for all tissue lines

A stem cell, embryonic stem cell technology, applied in the field of cell therapy, cell biology, stem cell therapy

Inactive Publication Date: 2007-05-30
PRIMEGEN BIOTECH LLC
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the use of stem cells from the bone marrow (ie, hematopoietic, stromal, and / or endothelial cells) and brain stem cells (ie, neuroblasts) has its limitations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stem cell maturation method for all tissue lines

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0041] Preparations of HSCs may be obtained from the same species, or they may be from different species. Transfer of HSCs can be into a host of the same species or into a host of a different species.

[0042] Alternatively, primed HSCs can be used to obtain cells for therapy in the treatment of abnormal conditions and tissue repair.

[0043] In another embodiment of the invention, the therapeutic composition comprises enucleated adult stem cells having nuclei from primordial sex cells or embryonic stem cells. Therapeutic compositions can be used to regenerate diseased or injured tissue of an animal in need thereof. Diseased or damaged tissue can include, for example, heart tissue, lung tissue, and other bodily tissue.

Embodiment 1

[0049] Example 1 Isolation of primordial sex cells (PSCs)

[0050] Anesthetize the mammal or animal, remove the gonads, and transect. Primary sex cells (PSCs) were isolated with the aid of a microscope. Alternatively, microscopically assisted isolation of PSCs can also be performed using biopsy punches from the gonads. Microscopically, PSCs have the morphology of stem cells (ie, large, round, smooth) that were mechanically retrieved from the gonads. In particular, spermatogonia and oogonia are retrieved from the gonads. In particular, type A and type B spermatogonia are retrieved.

[0051] To obtain egg(s), the animal is hyperovulated, at least one egg is retrieved, and placed alive on a nutrient medium. Using a micropipette to hold the egg in place, use another micropipette to enter the egg until the tip is adjacent to the nucleus of the egg. Enucleation of eggs can be done by applying a small amount of vacuum to a micropipette. Egg (ln) nuclei were discarded. The en...

Embodiment 2

[0053] Example 2 Isolation and Purification of Type A Spermatogonia

[0054] The following is an illustrative example for the isolation and purification of type A spermatogonia. In step 1, testes were removed from 6-day-old donor mice (n=8) and placed in petri cultures with sterile phosphate-buffered saline (PBS) containing 10% penicillin-streptomycin in the dish.

[0055] Next, in step 2, the testes are demembraned under a dissecting microscope, and the semiferous cord / tubule is collected, pooled, and placed in a conical centrifuge tube containing the following solution: Dulbecco modified A solution of 2 mg / ml collagenase (Sigma Chemicals, St. Louis, MO) and 10 μg / ml Dnase I (Sigma Chemicals, St. Louis, MO) in Eagle's medium (DMEM; Specialty Media).

[0056] In step 3, the centrifuged contents were incubated on a shaker at 37°C for 30 minutes with occasional gentle pipetting to separate the interstitial Leydig cells from the seminiferous tubules.

[0057] In step 4, afte...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a hybrid stem comprising an enucleated adult stem cell having a nucleus derived from a primordial sex cell or an embryonic stem cell. The primordial sex cell may be a spermatogonia or an oogonia from a donor animal or mammal. The enucleated adult stem cell may be fused to a primordial sex cell or an embryonic stem cell by many methods including but not limited to electrofusion, virus-based fusion methodology, chemical fusion or mechanical-based fusion.

Description

technical field [0001] The present invention relates to the field of cell biology. More specifically, the present invention relates to the field of cell therapy, especially stem cell therapy. The invention provides hybrid stem cells and related methods for their preparation and use. The hybrid stem cells of the invention can be used to treat diseased and damaged tissues and organs in mammals in need thereof. Background of the invention [0002] Since the first description of the isolation of embryonic stem cells from human embryonic cells, many reports have not covered the isolation and analysis of embryonic and adult stem cells in depth. Bongso, A.. et al. (1996), Isolation and culture of inner cell mass cells from human blastocyst, Hum. Reprod. U.S.A. 9, 2110-17. [0003] Stem cells (embryonic and adult) are capable of long-term self-renewal and can give rise to mature cell types with defined morphology and function. Similarly, the source of adult stem cells shares a c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/16A61K35/12C12N5/22C12M3/00C12N5/00C12N5/074C12N5/076
CPCC12N5/061C12N2509/00C12N2501/235C12N2517/04A61K35/12C12N5/0611A61P11/00A61P43/00A61P9/00
Inventor 昌西·B·赛亚
Owner PRIMEGEN BIOTECH LLC